knowledge -WSS

knowledge

author：leisure time 2025-08-12 06:44:39 - browse：6

Christoph Lengauer stands for a portrait. -- biotech coverage from STAT — Christoph Lengauer, co-founder and CSO of Curie.Bio Vanessa Leroy for STAT

Curie.Bio, the new biotech investment firm and incubator launched earlier this year by a group of industry veterans including Alexis Borisy and Zach Weinberg, has graduated its first startup.

The startup, Forward Therapeutics, is coming out of the incubator with three drug candidates for chronic inflammatory disorders. It also just closed its first major financing round: a $50 million Series A round led by BVF Partners, with participation from RA Capital Management and OrbiMed. That money should be enough for Forward to begin clinical trials — a rare feat in the biotech world, where companies often need to raise multiple private financing rounds in order to be ready for human tests.

“Usually, with Series A money, you get a development candidate, and use Series B to take molecules to the clinic,” Forward CEO Toufike Kanouni told STAT. But with the Curie team’s help, and the $8 million in seed financing it provided, Forward was able to move much faster.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： What causes osteoarthritis? Researchers study link to brain protein

focus

WSS

AstraZeneca to buy developer of next

Pumping milk in bathrooms at health conferences is common

Nurses recount patients attacks

The inclusion problem at the heart of rehabilitation research

To bolster infectious disease surveillance, genomics powerhouses team up

AstraZeneca to buy developer of next

focus

knowledge

entertainment

The high cost of giving birth even with insurance

AstraZeneca to buy developer of next

Sports medicine is finally prioritizing gender equality

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Peter Hotez and the public health issue of online harassment

Creating egg and sperm cells from stem cells raises ethical issues

Guidelines to prevent youth baseball injuries need more muscle

CVS is on a mission to consolidate health care. Will it work?

Novavax promises a turnaround & Lilly roils the obesity market

Future doctors should be trained to promote social change

explore

CVS is on a mission to consolidate health care. Will it work?

There's an unseen cost to disruptive road

CVS Caremark has created a new ploy: the drug ‘rebate credit’

HPV vaccine, cervical cancer study delivers historic results

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Dog Aging Project founders on what lies ahead after losing funding

knowledge

explore

focus

hotspot